LONDON BROKER RATINGS: JPMorgan lifts price targets for Dechra and GSK Read More
AIM WINNERS & LOSERS: accesso reports high demand; Ideagen, Abcam buy Read More
Abcam completes acquisition of life science research tool distributor Read More
LONDON BROKER RATINGS: Keppler Cheuvreux raises Pearson to Hold Read More
LONDON BROKER RATINGS: HSBC lifts Compass to Buy; RBC cuts JTC Read More
IN BRIEF: Abcam profit grows as lab activity and demand recover Read More
UK earnings, trading statements calendar - next 7 days Read More
PRESS: IP Group's Oxford Nanopore set for London float soon - Reuters Read More
EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out Read More
Abcam to acquire Boai NKY subsidiary BioVision for USD340 million Read More
LONDON MARKET PRE-OPEN: Meggitt agrees to GBP6.3 billion takeover Read More
Abcam trades in line with expectations as lab product demand limited Read More
UK shareholder meetings calendar - next 7 days Read More
BROKER RATINGS: HSBC cuts Burberry; Deutsche raises Travis Perkins Read More
Abcam confirms financial year-end date change to December 31 Read More
EXECUTIVE CHANGES: Imperial Brands CFO enters; DF Capital chair exits Read More
IN BRIEF: Avacta in global Affimer distribution agreement with Abcam Read More
DIRECTOR DEALINGS: Derwent London chair-designate Breuer buys shares Read More
BROKER RATINGS: BofA, Barclays and Goldman start Dr Martens coverage Read More
